Abstract
An MMLV-based retroviral vector containing the chloramphenicol acetyl transferase reporter gene under the control of a glucose-dependent internal promoter derived from the L-type pyruvate kinase gene was constructed. After transfection into psi-CRIP packaging cells, clones producing recombinant retrovirus were selected. These retroviruses were used to infect cultured established hepatocytic cells whose endogenous L-type pyruvate kinase gene is transcriptionally regulated by glucose. In the infected cells, the reporter gene was as responsive to glucose as the endogenous L-type pyruvate kinase gene, and the glucose gene activation was time- and concentration-dependent. The possibility to confer a glucose responsiveness on a transgene carried by a retroviral vector provides a powerful tool in the prospect of gene therapy for diabetes mellitus.
Original language | English (US) |
---|---|
Pages (from-to) | 223-226 |
Number of pages | 4 |
Journal | FEBS Letters |
Volume | 365 |
Issue number | 2-3 |
DOIs | |
State | Published - May 29 1995 |
Externally published | Yes |
Keywords
- Gene therapy
- Glucose responsiveness
- Hepatocytic cell
- Retroviral vector
ASJC Scopus subject areas
- Genetics
- Molecular Biology
- Biophysics
- Structural Biology
- Biochemistry
- Cell Biology